Nephrotic syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(7 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Nephrotic syndrome}}
{{Nephrotic syndrome}}


Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}; {{AE}} {{MJ}}


==Overview==
Multiple risk factors may be involved in the nephrotic syndrome, such as family history, gender, and [[obesity]]. Also, diseases such as [[Hodgkin's lymphoma|Hodgkin lymphoma]], [[leukemia]], [[Virus|viral]] diseases, and medications such as [[lithium]], [[D-penicillamine]] can be risk factors for developing different types of nephrotic syndromes.


__NOTOC__
{{Nephrotic syndrome}}
{{CMG}}; {{AE}} [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]]
==Overview==
==Risk factors==
==Risk factors==
Risk factors of nephrotic syndrome depend on the type of syndromes as below:
Risk factors of nephrotic syndrome depend on the type of syndromes, as below:


=== Common risk factors ===
=== Common risk factors ===
Risk factors of development of minimal change disease include:<ref name="IijimaHamahira20022">{{cite journal|last1=Iijima|first1=Kazumoto|last2=Hamahira|first2=Kiyoshi|last3=Tanaka|first3=Ryojiro|last4=Kobayashi|first4=Akiko|last5=Nozu|first5=Kandai|last6=Nakamura|first6=Hajime|last7=Yoshikawa|first7=Norishige|title=Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome|journal=Kidney International|volume=61|issue=5|year=2002|pages=1801–1805|issn=00852538|doi=10.1046/j.1523-1755.2002.00303.x}}</ref>
Risk factors of development of [[minimal change disease]] include:<ref name="IijimaHamahira20022">{{cite journal|last1=Iijima|first1=Kazumoto|last2=Hamahira|first2=Kiyoshi|last3=Tanaka|first3=Ryojiro|last4=Kobayashi|first4=Akiko|last5=Nozu|first5=Kandai|last6=Nakamura|first6=Hajime|last7=Yoshikawa|first7=Norishige|title=Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome|journal=Kidney International|volume=61|issue=5|year=2002|pages=1801–1805|issn=00852538|doi=10.1046/j.1523-1755.2002.00303.x}}</ref>
* Children within the Age >1 year but <8 years
* Children within the Age >1 year but <8 years
* [[Hodgkin's lymphoma|Hodgkin lymphoma]]
* [[Hodgkin's lymphoma|Hodgkin lymphoma]]
* [[Leukemia]]
* [[Leukemia]]
* Recent viral illness
* Recent viral illness
* Toxins such as [[Mercury (element)|mercury]], [[gold]], bee stings, fire coral exposure are some of the causes for minimal change disease.
* Toxins such as [[Mercury (element)|mercury]], [[gold]], bee stings, fire coral exposure.
* Medication such as<ref name="pmid279404603">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref>
* Medication such as<ref name="pmid279404603">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref>
**Salazopyrin
**Salazopyrin
Line 26: Line 23:
** [[D-penicillamine]]
** [[D-penicillamine]]
** Tyrosine-kinase inhibitor
** Tyrosine-kinase inhibitor
The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):<ref name="FSGS">{{cite web |url= http://cdn.intechopen.com/pdfs/22820/InTech-Focal_segmental_glomerulosclerosis.pdf|title= Focal segmental glomerulosclerosis.|last1= Sohal |first1= DS |last2= Prabhakar |first2= SS |date=November 02, 2011|website= Interchopen |publisher= InTech |accessdate=3 December 2013}}</ref>
The following are considered risk factors for the development of [[focal segmental glomerulosclerosis]] ([[Focal segmental glomerulosclerosis|FSGS]]):<ref name="FSGS">{{cite web |url= http://cdn.intechopen.com/pdfs/22820/InTech-Focal_segmental_glomerulosclerosis.pdf|title= Focal segmental glomerulosclerosis.|last1= Sohal |first1= DS |last2= Prabhakar |first2= SS |date=November 02, 2011|website= Interchopen |publisher= InTech |accessdate=3 December 2013}}</ref>
* Male gender
* Male gender
* Black race
* Black race
Line 38: Line 35:
=== Less common risk factors ===
=== Less common risk factors ===
Below conditions and toxins can be a risk factor for nephrotic syndrome<ref name="pmid12944064">{{cite journal| author=Eddy AA, Symons JM| title=Nephrotic syndrome in childhood. | journal=Lancet | year= 2003 | volume= 362 | issue= 9384 | pages= 629-39 | pmid=12944064 | doi=10.1016/S0140-6736(03)14184-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12944064 }}</ref>
Below conditions and toxins can be a risk factor for nephrotic syndrome<ref name="pmid12944064">{{cite journal| author=Eddy AA, Symons JM| title=Nephrotic syndrome in childhood. | journal=Lancet | year= 2003 | volume= 362 | issue= 9384 | pages= 629-39 | pmid=12944064 | doi=10.1016/S0140-6736(03)14184-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12944064 }}</ref>
<div style="-moz-column-count:2; column-count:2;">
*Adaptation to [[nephron]] reduction
*Adaptation to [[nephron]] reduction
*[[Amyloidosis]]
*[[Amyloidosis]]
*[[Bee sting]]
*[[Bee sting]]
*[[Castleman's disease]]
*[[Castleman's disease]]
*[[Chronic interstitial nephritis]]
*[[Chronic interstitial nephritis]]
Line 49: Line 46:
*[[Fabry's disease]]
*[[Fabry's disease]]
*[[Food allergens]]
*[[Food allergens]]
*[[Gold]]
*[[Gold]]
*[[Goodpasture's syndrome]]
*[[Goodpasture's syndrome]]
Line 88: Line 84:
*[[Vasculitis]]
*[[Vasculitis]]
*[[Viral hepatitis]]
*[[Viral hepatitis]]
</div>
====Drug Induced====
====Drug Induced====
<div style="-moz-column-count:2; column-count:2;">
*[[Agalsidase beta]]
*[[Agalsidase beta]]
*[[Certolizumab pegol]]
*[[Certolizumab pegol]]
Line 96: Line 94:
*[[Trimethadione]]
*[[Trimethadione]]
*[[Ziv-aflibercept]]
*[[Ziv-aflibercept]]
</div>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Kidney diseases]]
 
[[Category:Medicine]]
[[Category:Nephrology]]
[[Category:Nephrology]]
[[Category:Pediatrics]]
[[Category:Up-To-Date]]
[[Category:Disease]]
[[Category:Emergency medicine]]
[[Category:Syndromes]]
[[Category:Needs content]]
[[Category:Primary care]]
 
{{WH}}
{{WS}}

Latest revision as of 22:58, 29 July 2020

Nephrotic Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nephrotic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X-Ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nephrotic syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nephrotic syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nephrotic syndrome risk factors

CDC on Nephrotic syndrome risk factors

Nephrotic syndrome risk factors in the news

Blogs on Nephrotic syndrome risk factors

Directions to Hospitals Treating Nephrotic syndrome

Risk calculators and risk factors for Nephrotic syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

Multiple risk factors may be involved in the nephrotic syndrome, such as family history, gender, and obesity. Also, diseases such as Hodgkin lymphoma, leukemia, viral diseases, and medications such as lithium, D-penicillamine can be risk factors for developing different types of nephrotic syndromes.

Risk factors

Risk factors of nephrotic syndrome depend on the type of syndromes, as below:

Common risk factors

Risk factors of development of minimal change disease include:[1]

The following are considered risk factors for the development of focal segmental glomerulosclerosis (FSGS):[3]

  • Male gender
  • Black race
  • Family history
  • Heroin abuse
  • Drugs known to be associated with FSGS
  • Chronic viral infection
  • Single kidney status
  • Obesity

Less common risk factors

Below conditions and toxins can be a risk factor for nephrotic syndrome[4]

Drug Induced

References

  1. Iijima, Kazumoto; Hamahira, Kiyoshi; Tanaka, Ryojiro; Kobayashi, Akiko; Nozu, Kandai; Nakamura, Hajime; Yoshikawa, Norishige (2002). "Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome". Kidney International. 61 (5): 1801–1805. doi:10.1046/j.1523-1755.2002.00303.x. ISSN 0085-2538.
  2. Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
  3. Sohal, DS; Prabhakar, SS (November 02, 2011). "Focal segmental glomerulosclerosis" (PDF). Interchopen. InTech. Retrieved 3 December 2013. Check date values in: |date= (help)
  4. Eddy AA, Symons JM (2003). "Nephrotic syndrome in childhood". Lancet. 362 (9384): 629–39. doi:10.1016/S0140-6736(03)14184-0. PMID 12944064.